Based in Germany, WMT AG is a startup.
WMT AG is a biotech company based in Heidelberg developing precisely engineered small molecules that inhibit proliferating overactivated cells using their novel Translational Trap technology, targeting diseases such as cancer, autoimmune disorders, and viral infections.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.